What is Xanax?
Xanax is a tranquilizer (anxiogenic medication) with antidepressant, hypnotic, and anticoagulant action. The principle active ingredient is the derivative of triazole-benzodiazepine. For the treatment of depressive conditions and other mental disorders, Xanax pills containing 0.25 mg, 0.5 mg, 1 mg, 2 mg or 3 mg of the active substance may be prescribed.
Xanax inhibits spinal reflexes, limbic system, thalamus and hypothalamus in poly synaptic form. Anxiety and emotional stress diminish under its influence, and a sense of anxiety and fear is diminished. Xanax causes relaxation of the muscles and has a gently hypnotic effect. Patients fall asleep quicker while taking Xanax, the length of the sleep increases, and the number of nocturnal awakenings decreases.
Guidelines for Xanax use (Alprazolam)
This medication is prescribed for neurotic and neurosis-like disorders in which the patient has an anxiety feeling. Alprazolam and analogs are effective in treating reactive depressive disorders, including those that have developed against somatic disease backgrounds. In the case of panic disorders; insomnia; abstinence syndrome (including alcohol and drug dependence); senile and essential tremors, this medicine is also indicated.
Dizziness, poor focus, drowsiness; less frequent–fatigue, insomnia, visual impairment, anxiety, depression, memory impairment, concentrating trouble, lack of balance, irritability, confusion, agitation, hallucinations, dystonia, anorexia, muscle weakness, urinary incontinence, menstrual irregularities and diminished function of the kidneys. There is a risk of developing drug dependence.
In the following cases, Alprazolam is contraindicated: severe respiratory failure; hypersensitivity to the drug components; Closed-angle glaucoma; acute liver and kidney disease; Myasthenia gravis; Acute alcoholic poisoning.
Furthermore, the medication is not recommended for pregnant women (especially in the first trimester) and women who are breastfeeding, as well as children under 18.
Patients with chronic hepatic or renal insufficiency, cerebral and spinal ataxia, drug dependence, hyperkinesis, organic brain disorders, paranoia, hypoproteinemia, and sleep apnea should use Xanax with caution.
Using Xanax (Alprazolam) at the same time as another relieving agent is inadmissible. Alprazolam patients should refrain from all activities which require increased attention, rapid physical and mental reactions.
To increase awareness of evidence based approach in herbal medicine and to face the lack of regulations in this type of treatments students of the second year at the Faculty of Pharmacy, Cairo University, undertook a project to prepare 60 monographs for 60 medicinal plants that have clinically proved medicinal effects and used as pharmaceutical products their work were guided by WHO publications in this regard to spread the scientific evidence in the field of Herbal medicine where students presented 60 booklets, each booklet contains a complete description of one of the medicinal plants followed by a careful description of its active substances and pharmacological effects, the mechanism of action of these active substances in our body, side effects, contraindications and plant risk or safety to pregnant women and pediatrics and the difference between its uses in folk medicine and what it has actually proven in clinical studies with the addition of pictures of the plant and its pharmaceutical products in the markets. To emphasize the necessity of a scientific evidence this information has been supported by recent references and research has also been provided. In ten-minute each team present explanation and sumarrized the latest research Published in international journals on each plants and students were able, despite the of their second year university stage, to prove scientific evidence and search in global search engines and understand the monograph content and provided a full explanation for evidence base info
Personalised feedback dummy data for use in Prato 2019 workshop
This is the EPA Tool which utilised the ePortfolio COMeT in oder to make EPA recording more efficient and consistent across all placement sites. Preceptors are required to register in order to use the tool.
With the excellent accomplishment of Pharmacovigilance Series of Conferences in the UK, the USA in back to back a long time in the course of the most recent quite a while which met with extraordinary accomplishment in Business Conferencing.
Pharma Middle East 2019 is the most suitable platform to explore ones’ scientific knowledge by sharing trough their presentations and to build a robust network with the eminent people, key decision makers from all-around the academic institutions, Healthcare Institutes, Pharmaceutical, Biotech or
This is a test of exporting an exercise from MyDispense and making it available in PharmAcademy
Thursday, September 13, 2018 at 9AM Pacific/10AM Mountain/11AM Central/12PM Eastern (1 hour duration)
At the conclusion of this program, participants will be able to:
- Articulate the "hidden importance" of peer review
- Identify valued behaviors and actions of peer reviewers from an Editor's perspective and a Journal Manager's Perspective
- Discuss a freely available training program to aid peer reviewer development
- Describe methods for utilizing available resources to support new reviewers (e.g. faculty, residents, graduate students)
More events can be found on the PRW Twitter Feed: @PeerRevWeek. If you are not a Twitter user, you can read the feed here: https://peerreviewweek.wordpress.com/.
- Andrew Bzowyckyj, Pharm.D., Pacific University School of Pharmacy and Associate Editor for LEADeR Reports, Currents in Pharmacy Teaching and Learning
- Kristin Janke, Ph.D., University of Minnesota College of Pharmacy, Editor, Innovations in Pharmacy – Education Section and Executive Associate Editor, Currents in Pharmacy Teaching and Learning.
- Kully Rennie, Journal Manager, Pharmacy Education
- Andy Traynor, Pharm.D., Concordia University –Wisconsin, Associate Editor for Peer Reviewer Development, Currents in Pharmacy Teaching and Learning and Editor, Innovations in Pharmacy – Community Engagement and Leadership.
- Robin Zavod, Ph.D., Midwestern University – Chicago and Editor-in-Chief, Currents in Pharmacy Teaching and Learning
This is an example of a series of pre-lab video resources we have developed over the last 7 years at the University of Namibia. Initially a paper-based resource but with increasing numbers of students and educational programmes we developed the videos to increase the efficiency of the labs. Students must watch the video prior to attendance of the lab so that they are better prepared; a short quiz is given at the beginning of that lab to ensure that they watch the video. We have deliberately tried to make these videos and the lab resource relevant to health sciences disciplines (not just pharmacy), improve the relevance, and increase the impact of training. We hope that this resource can be utilised in other low-resource settings. We would appreciate feedback: https://www.youtube.com/watch?v=nTuIyZZtf3k&list=PLWyvZNcql_MYsTSCgJQ_pKqnfOsCTZpJ4
Nano Delivery 2019, London Conference highlights the theme “Emerging trends of Nanomedicine and Drug Delivery Research” during March 18-20,2019 in London .
International Pharmaceutical Federation (FIP) is inviting deans, vice-deans or leadership team members of the schools of pharmacy & pharmaceutical sciences to the FIP Global Deans Forum, on 1-2 September 2018 in Glasgow, UK. Leading experts from Harvard University and University of Strathclyde will provide highly rewarding 1,5 days of workshops on Strategic Planning & Change Management and Conflict Resolution.
On day one, Dr James Honan, of Harvard University, will lead a full day session on Strategic Planning and Change Management. Deans will take home ideas to transform concepts into a strategy and a business plan, with a clear vision, mission and objectives. On Day two, Strathclyde University’s HR leaders in higher education, Sandra Heidinger and Alison Locke, will take the deans through conflict resolution strategies for effective HR management at their institutions. Case studies and interactive workshops on conflict resolution will support the deans to enable transformational change through people and drive institutional success. To join and find out more, please contact: firstname.lastname@example.org or visit https://bit.ly/2zsJGTv
New features for mydispense
Ideas for MyDispense developments